| 0.2066 0.002 (0.78%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.3 |
1-year : | 0.36 |
| Resists | First : | 0.26 |
Second : | 0.31 |
| Pivot price | 0.21  |
|||
| Supports | First : | 0.17 | Second : | 0.14 |
| MAs | MA(5) : | 0.2 |
MA(20) : | 0.21 |
| MA(100) : | 0.27 |
MA(250) : | 0.49 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 44.9 |
D(3) : | 45.2 |
| RSI | RSI(14): 44.8 |
|||
| 52-week | High : | 1.32 | Low : | 0.16 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ COSM ] has closed above bottom band by 35.2%. Bollinger Bands are 49.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.21 - 0.22 | 0.22 - 0.22 |
| Low: | 0.2 - 0.2 | 0.2 - 0.2 |
| Close: | 0.2 - 0.21 | 0.21 - 0.21 |
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Tue, 18 Aug 2026
Cosmos Health Inc. (COSM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Tue, 18 Aug 2026
Cosmos Health Inc. 2026: Revenue $18.99M, EPS ($0.1) — 10-Q Summary - TradingView
Tue, 18 Aug 2026
Cosmos Health (NASDAQ: COSM) grows revenue yet flags doubt about its future - Stock Titan
Fri, 14 Aug 2026
Cosmos Health Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Fri, 14 Aug 2026
MSN Money - MSN
Wed, 22 Jul 2026
Cosmos Health Inc. SEC Filing (Jul 22, 2026) - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 62 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 36.3 (%) |
| Held by Institutions | 5.1 (%) |
| Shares Short | 5,600 (K) |
| Shares Short P.Month | 2,340 (K) |
| EPS | -0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.4 |
| Profit Margin | -30.5 % |
| Operating Margin | -12.2 % |
| Return on Assets (ttm) | -18.8 % |
| Return on Equity (ttm) | -92.4 % |
| Qtrly Rev. Growth | 30.7 % |
| Gross Profit (p.s.) | 0.11 |
| Sales Per Share | 1.11 |
| EBITDA (p.s.) | -0.27 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.32 |
| PEG Ratio | 0 |
| Price to Book value | 0.51 |
| Price to Sales | 0.18 |
| Price to Cash Flow | -1.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|